RETINOIC ACID RECEPTORS AND HEMATOPOIESIS
RETINOIC ACID RECEPTORS AND HEMATOPOIESIS
批准号:
2654102
负责人:
STEVEN Collins COLLINS
金额:
$22.87万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-04-01 至 2001-01-31
关键词:
CD34 molecule Retroviridae bone marrow cell cycle cell differentiation cell growth regulation cell population study erythroid stem cell hematopoiesis hematopoietic stem cells human tissue inhibitor /antagonist interleukin 1 interleukin 3 interleukin 4 interleukin 6 laboratory mouse lymphocyte myeloid stem cell neutrophil retinoate retinoid binding proteins tissue /cell culture transfection /expression vector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from investigator's abstract) Retinoic acid (RA)
and RA receptors (RARs) are involved in regulating the growth and
differentiation of multiple different cell types. To explore the role
of RA in hematopoiesis, the investigators have utilized retroviral
vectors harboring a dominant negative RAR to interfere with normal
endogenous RAR activity in different hematopoietic cells. They have
observed in cultures of normal mouse bone marrow that inhibiting
endogenous RA receptor activity in the presence of different
hematopoietic growth factors results in the establishment of
hematopoietic cell lines frozen at specific stages of neutrophil
differentiation. The investigators wish to further extend these studies
defining the role of RA receptors in hematopoiesis as follows. Specific
Aim 1: Determine whether the cultured lymphohematopoietic EML cells can
function as hematopoietic stem cells in irradiated mice. By infecting
normal mouse bone marrow with a retroviral vector harboring a dominant
negative RA receptor construct, the investigators have reproducibly
derived stem cell factor-dependent cell lines that display
characteristics of self-renewing lympho-hematopoietic progenitors
(designated EML). The investigators will formally evaluate the stem
cell activity of these cultured EML cells by assessing their ability to
act as hematopoietic stem cells in vivo in irradiated syngeneic mice.
Specific Aim 2: Utilize the dominant negative RA receptor retroviral
vector to establish hematopoietic growth factor dependent hematopoietic
stem cell lines. To further explore the RA receptors in regulating the
commitment and differentiation of lineages of hematopoietic stem cells
and progenitors, the investigators will culture bone marrow infected
with the dominant negative RA receptor retroviral construct with
specific hematopoietic growth factors including IL-1, IL-3 IL-4, IL-6,
flk2/flt3 ligand and TPO in an attempt to establish other growth factor
dependent cell lines frozen at different stages of hematopoietic
differentiation. Specific Aim 3: Utilize the dominant negative RA
receptor retroviral vector to establish growth factor dependent
lymphohematopoietic progenitor lines from human bone marrow. Specific
Aim 4: Determine the effect of RA receptor antagonists in the self
renewal and proliferation of cultured mouse and human stem cells. The
investigators will use synthetic retinoids exhibiting RA receptor
antagonist activity in attempts to optimize in vitro conditions that
enhance self-renewal and proliferation of hematopoietic stem cells while
blocking their differentiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Career and Mentoring Development Program
-
批准号:7727541
-
项目类别:
-
资助金额:$7.23万
-
财政年份:2009
-
负责人:STEVEN Collins COLLINS
-
依托单位:
Targeting the CaM Kinase Cascade in Treating Myeloid Leukemia
-
批准号:7246550
-
项目类别:
-
资助金额:$26.84万
-
财政年份:2006
-
负责人:STEVEN Collins COLLINS
-
依托单位:
Targeting the CaM Kinase Cascade in Treating Myeloid Leukemia
-
批准号:7434035
-
项目类别:
-
资助金额:$26.84万
-
财政年份:2006
-
负责人:STEVEN Collins COLLINS
-
依托单位:
Targeting the CaM Kinases in Treating Myeloid Leukemia
-
批准号:7146498
-
项目类别:
-
资助金额:$27.64万
-
财政年份:2006
-
负责人:STEVEN Collins COLLINS
-
依托单位:
Targeting the CaM Kinases in Treating Myeloid Leukemia
-
批准号:7626246
-
项目类别:
-
资助金额:$26.84万
-
财政年份:2006
-
负责人:STEVEN Collins COLLINS
-
依托单位:
RA RECEPTOR REGULATION ON HEMATOPOIETIC STEM CELLS
-
批准号:6652839
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2002
-
负责人:STEVEN Collins COLLINS
-
依托单位:
RA RECEPTOR REGULATION ON HEMATOPOIETIC STEM CELLS
-
批准号:6494847
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2001
-
负责人:STEVEN Collins COLLINS
-
依托单位:
RA RECEPTOR REGULATION ON HEMATOPOIETIC STEM CELLS
-
批准号:6358968
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2000
-
负责人:STEVEN Collins COLLINS
-
依托单位:
HEMOPOIETIC STEM CELL SELF RENEWAL AND RETINOID ANTAGONISTS
-
批准号:6202419
-
项目类别:
-
资助金额:$20.18万
-
财政年份:1999
-
负责人:STEVEN Collins COLLINS
-
依托单位:
HEMOPOIETIC STEM CELL SELF RENEWAL AND RETINOID ANTAGONISTS
-
批准号:6110531
-
项目类别:
-
资助金额:$20.18万
-
财政年份:1998
-
负责人:STEVEN Collins COLLINS
-
依托单位:
HEMOPOIETIC STEM CELL SELF RENEWAL AND RETINOID ANTAGONISTS
-
批准号:6242525
-
项目类别:
-
资助金额:$20.27万
-
财政年份:1997
-
负责人:STEVEN Collins COLLINS
-
依托单位:
RETINOIC ACID RECEPTORS AND HEMATOPOIESIS
-
批准号:6150129
-
项目类别:
-
资助金额:$24.63万
-
财政年份:1996
-
负责人:STEVEN Collins COLLINS
-
依托单位:
RETINOIC ACID RECEPTORS AND HEMATOPOIESIS
-
批准号:2098987
-
项目类别:
-
资助金额:$21.62万
-
财政年份:1996
-
负责人:STEVEN Collins COLLINS
-
依托单位:
RETINOIC ACID RECEPTORS AND HEMATOPOIESIS
-
批准号:2330818
-
项目类别:
-
资助金额:$22.23万
-
财政年份:1996
-
负责人:STEVEN Collins COLLINS
-
依托单位:
RETINOIC ACID RECEPTORS AND HEMATOPOIESIS
-
批准号:2871786
-
项目类别:
-
资助金额:$23.94万
-
财政年份:1996
-
负责人:STEVEN Collins COLLINS
-
依托单位:
RETINOIC ACID RECEPTORS AND MYELOPOIESIS
-
批准号:2098986
-
项目类别:
-
资助金额:$15.29万
-
财政年份:1993
-
负责人:STEVEN Collins COLLINS
-
依托单位:
RETINOIC ACID RECEPTOR IN MYELOID LEUKEMIA
-
批准号:3199939
-
项目类别:
-
资助金额:$0.33万
-
财政年份:1993
-
负责人:STEVEN Collins COLLINS
-
依托单位:
RETINOIC ACID RECEPTORS AND MYELOPOIESIS
-
批准号:3202440
-
项目类别:
-
资助金额:$13.72万
-
财政年份:1993
-
负责人:STEVEN Collins COLLINS
-
依托单位:
RETINOIC ACID RECEPTOR IN MYELOID LEUKEMIA
-
批准号:2096598
-
项目类别:
-
资助金额:$0.34万
-
财政年份:1993
-
负责人:STEVEN Collins COLLINS
-
依托单位:
RETINOIC ACID RECEPTORS AND MYELOPOIESIS
-
批准号:2098985
-
项目类别:
-
资助金额:$14.2万
-
财政年份:1993
-
负责人:STEVEN Collins COLLINS
-
依托单位: